Therefore, determining whether the suspension of anti-VEGF treatment affects the expansion of RPE atrophy should provide new information for deciding whether to continue or discontinue anti-VEGF treatments for eyes with nAMD. This evidence concerns the gene VEGFA and Atrophy.